A Bayesian semi-parametric model for learning biomarker trajectories and changepoints in the preclinical phase of Alzheimer’s disease
Biometrics · 27.03.2024 · 80 (2)
DOI: 10.1093/biomtc/ujae048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, online erschienen am 22.05.2024. Verfasst von Kunbo Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD 21218, United States. Hauptthemen laut MEDLINE: Alzheimer Disease, Bayes Theorem, Biomarkers, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIA NIH HHS, NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
It has become consensus that mild cognitive impairment (MCI), one of the early symptoms onset of Alzheimer’s disease (AD), may appear 10 or more years after the emergence of neuropathological abnormalities. Therefore, understanding the progression of AD biomarkers and uncovering when brain alterations begin in the preclinical stage, while patients are still cognitively normal, are crucial for effective early detection and therapeutic development. In this paper, we develop a Bayesian semiparametric framework that jointly models the longitudinal trajectory of the AD biomarker with a changepoint relative to the occurrence of symptoms onset, which is subject to left truncation and right censoring, in a heterogeneous population. Furthermore, unlike most existing methods assuming that everyone in the considered population will eventually develop the disease, our approach accounts for the possibility that some individuals may never experience MCI or AD, even after a long follow-up time. We evaluate the proposed model through simulation studies and demonstrate its clinical utility by examining an important AD biomarker, ptau181, using a dataset from the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD 21218, United States.
- Department of Biostatistics, Johns Hopkins University, Baltimore, MD 21205, United States.
ORCID-Profile: Kunbo Wang, MeiCheng Wang, Yanxun Xu
Förderung
- NIMH NIH HHS
- NIA NIH HHS
- NIH HHS
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Wang, K., Hua, W., Wang, M., & Xu, Y. (2024). A Bayesian semi-parametric model for learning biomarker trajectories and changepoints in the preclinical phase of Alzheimer’s disease. Biometrics, 80(2). https://doi.org/10.1093/biomtc/ujae048
Vancouver
Wang K, Hua W, Wang M, Xu Y. A Bayesian semi-parametric model for learning biomarker trajectories and changepoints in the preclinical phase of Alzheimer’s disease. Biometrics. 2024;80(2). doi:10.1093/biomtc/ujae048
BibTeX
@article{Wang2024,
author = {Wang, Kunbo and Hua, William and Wang, MeiCheng and Xu, Yanxun},
title = {A Bayesian semi-parametric model for learning biomarker trajectories and changepoints in the preclinical phase of Alzheimer’s disease},
journal = {Biometrics},
year = {2024},
volume = {80},
number = {2},
doi = {10.1093/biomtc/ujae048}
}
EUVIMED